Community-Acquired Pneumonia
HTML-код
- Опубликовано: 28 мар 2025
- Learning objective 1. Describe the pharmacokinetic and pharmacodynamic properties of antibiotics used for pneumonia.
Learning objective 2. Distinguish between various types of pneumonia using patient-specific factors, clinical manifestations, and diagnostic testing.
Learning objective 3. Use risk stratification tools to assess a patient’s risk with pneumonia and aid in determining setting of treatment.
Learning objective 4. List the likely causative pathogens for each type of pneumonia, including susceptibility profiles and patient risk factors for multidrug-resistant pathogens.
Learning objective 5. Given a patient with community-acquired pneumonia, design appropriate empiric therapy.
Learning objective 6. Recommend an appropriate duration of therapy for community-acquired pneumonia.
![🧫 Urinary Tract Infections (UTIs) [2024 Update]](http://i.ytimg.com/vi/LJGxDUA1-qs/mqdefault.jpg)
![[BONUS] Quand le patron du PSG impose sa loi aux autres présidents de club (Version longue)](http://i.ytimg.com/vi/xjZeo7FIWQg/mqdefault.jpg)
Thanks a lot , it was very informative and easy to understand, appreciated
My dad has pneumonia, they gave him 5 days of amoxicillin and azitromycin but after five days he still had a fever. So now he is taking a 10 day course of Levofloxacin 500mg PO. I’m praying this helps him since this has really knocked him hard.
Just love these lectures!
Why osletamivir and anitibiotcs given for a pneumonia patient before identifying the microorganism bcoz my patient have fungal pneumonia but before identifying the organism they give antiviral and antibiotics
Doctor we need lecture about community acquired meningitis and health care associated meningitis
I can not thank you enough